Institutional investors hold a majority ownership of AMGN through the 83.24% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
AXA INVESTMENT MANAGERS UK LTD. Bought 121.3 Thousand shares of Amgen
HANDELSBANKEN FONDER AB Bought 118.3 Thousand shares of Amgen
3 BANKEN-GENERALI INVESTMENT-GES... Bought 64.5 Thousand shares of Amgen